
Founder: Arthur Fonseca | Location: New York - NY
The U.S. spends over $4.5 trillion a year on healthcare, yet 90% of costs are driven by preventable chronic diseases.
Omega Health aims to close this gap by becoming the nation’s leading provider of low-cost, personalized longevity plans. Through early detection and actionable insights, we empower individuals to live longer, healthier lives, and give employers a scalable way to reduce long-term health costs. We’re transforming longevity from a luxury to an accessible daily tool.

Our customized plans leverage cutting-edge AI and longevity principles to help you live your best, longest life.
Our longevity plan starts with a blood test, analyzed by AI to create a personalized report with actionable steps to improve health and extend lifespan.
We partner with payroll and benefits providers to integrate our innovative platform as a seamless, subscription-based employee wellness solution.



Our focus is on partnering with payroll companies and benefit brokers to offer our personalized health plans as an employee benefit, seamlessly integrating into existing benefits packages.

The Latest Data Indicates there are approximately 7,700*payroll providers and benefits brokers in the U.S. The top three payroll providers - Intuit Quickbooks, ADP, and Paycheck Flex-covers almost half (45%) of SMB employers nationwide.
*June 2022

Approximately 161.49* million people are employed in the United States. This number reflects the total non farm payroll employment, which includes workers across various sectors and industries (Bureau of Labor Statistics).
*April 2024

Our goal is to engage just 0.0415% of the U.S. workforce - 66,889 subscribers - over the next five years. This represents a highly conservative penetration rate in a market of more than 160 million people. Delivered through nationwide payroll and broker channels.

CEO
Drives Omega Health’s mission to make personalized health plans accessible, transforming human longevity through innovative solutions.
CMO
Board-Certified Internal Medicine physician specializing in anti-aging and regenerative medicine, and author of health books.
Advisor
Internal Medicine physician with residency training through Stamford Hospital/Columbia University and teaching faculty role with Rutgers University.
COO
Optimizes operations and drives efficiency at Omega Health with 10 years of healthcare consulting experience.
CTO
Software Engineering leader and founder of a multi-industry software company, guiding Omega Health's technology.
Advisor
Supply chain executive with experience at Campari, L’Oréal, and Unilever, advising on operational strategy.
Advisor
Investment Banking Executive Director with an MBA from Cornell, providing strategic guidance on business growth and fundraising.
Our scalable subscription model and strategic partnerships drive rapid growth. Plans are projected to be priced at $25/month, with employers covering a significant portion, making it affordable option for employees. Our lean costs enable high-value services at low operational expenses.


Companies in the diagnostics + longevity space are achieving high valuations — Function Health raised a US$53 million Series A in 2024; Viome raised an US$86.5 million Series C in 2023; and InsideTracker raised a US$15 million Series B in 2022, demonstrating strong investor confidence in longevity platforms and supporting our conservative 5×-revenue multiple for Omega Health.





Where longevity plans are delivered. Step-by-step, progressive guidance


GLP-1 weight management, hormone & peptide therapies. Physician-guided prescription treatments


Advanced, highly personalized plans designed for high-touch support


Designed to support longevity protocols
Seeking investment in exchange for equity
Ownership stake for investors
Capital to complete launch readiness, commercialize Omega, and validate early market demand, we will allocate these funds across four strategic areas:
Complete final security, compliance, and operational requirements for commercial launch.
Finalize the Omega platform, deploy mobile apps, and optimize the product through real-world user validation.
Convert the existing waitlist, launch customer acquisition, and expand Omega Longevity and Omega Clinical.
Generate early traction, strengthen unit economics, and position Omega for its next institutional fundraising round.
Omega is entering its next phase: commercial launch, real-world validation, and revenue generation.
With $150,000 in total capital invested to date from the founder and early investors, we are now completing our pre-seed round to accelerate launch, introduce our GLP-1 offering, convert early demand into customers, and scale the Omega ecosystem.
Join us in building a more accessible, personalized approach to longevity.
Get in touch today to discuss investment opportunities via email at arthur@omegagenetics.ai, by phone at (551) 255-4877, or visit our website at www.omegagenetics.ai.
